Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AerCap Leased, Purchased and Sold 152 Assets in the First Quarter 2024
-
Sierra Metals Announces Intention to List on the Lima Stock Exchange
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Bluevine Helps Small Businesses Quickly Unlock Growth With A Choice Of Three Business Checking Plans Designed To Maximize Earnings and Minimize Fees
-
Checkmarx One Total Economic Impact Study Finds Return on Investment of 177% in Fewer Than Six Months and Gain of $7.13M in Benefits Over Three Years
-
ProfoundBio to Present Data on Multiple Preclinical Programs From Its Antibody-Drug Conjugate Pipeline at the American Association for Cancer Research Annual Meeting 2024
-
Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery
-
Lifeguard Digital Health Partners with Pathways to Housing PA to Assist with Safer Living for Vulnerable Individuals in Philadelphia
-
Lantronix Showcases New Campus PoE++ Switches, Pre-Configured With Percepxion Cloud Management Software
-
Betterworks 2024 Performance Enablement Report Reveals Substantial Gaps Between Organizational Leaders and Employees That Threaten to Undermine Productivity
-
Phenomix Sciences Launches Three-in-One Obesity Phenotyping Test, Adding Emotional Hunger and Personalized Lifestyle Guidance
-
MiNA Therapeutics Enters Research Collaboration with Nippon Shinyaku to Develop RNAa Therapeutics Targeting Rare Neurodegenerative Diseases
-
Aduro Clean Technologies Provides Update on Joint Western University Research Project
-
World Silver Medalist Heptathlete Anna Hall and Her Labrador Emma Partner with Nulo
-
HEALWELL AI’s Pentavere Achieves Validation of Generative AI for Preventative Care Through Landmark Publication
-
Gennao Bio Announces Upcoming Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
-
ProMIS Neurosciences to Present in Upcoming Investor Conferences in April
-
Mayfair Gold Sets the Record Straight and Corrects Muddy Waters’ Misleading and Inaccurate Statements
-
Tim Lamb Group Brokers Sale of Metro Toyota in Brook Park, Ohio to Victory Automotive Group
-
Tilray Brands Announces 420 Activations Across Canada and Unveils Celebratory Product Lineup
-
Psychological Safety in Today’s Global Workforce
-
GXO Schedules First Quarter 2024 Earnings Conference Call for Wednesday, May 8, 2024
-
e2Companies Identifies Global Power Leader Cummins Inc. as Strategic Supplier for the R3Di® System
-
NOG Schedules First Quarter 2024 Earnings Release and Conference Call
-
OTC Markets Group Welcomes DSM Firmenich AG to OTCQX
-
OTC Markets Group Welcomes Horizon Copper Corp. to OTCQX
-
ZeroFox Wins Multiple Industry Awards and Reinforces Digital Risk Protection Leadership Position
-
100 Best Companies to Work For in 2024 Deliver ‘Staggering’ Business Performance
-
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
-
AS Tallink Grupp Audited Annual Report for the Financial Year 2023
-
Siili Solutions Plc: Change in management team
-
London's Historic Vacation Rental Boom Revives Luxury Heritage says The Urban Retreat Apartments
-
ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
-
Johnson & Johnson to Showcase its Broad Scientific Leadership and Latest Innovations to Combat Cardiovascular Disease at ACC.24
-
Flash News: OKX Launches Cryptopedia Season 15, Offering Users Up to USD300,000 in ZKL Tokens for Completing Quests
-
Man Group PLC : Form 8.3 - Redrow plc
-
Petro-Victory Energy Corp. Provides Update on SJ-06 Well Workover at 100% Owned São João Field Located in Northeast Brazil in The Barreirinhas Basin
-
HSBC Continental Europe: Pre Stabilisation Notice
-
AECOM consortium selected to deliver Australia’s M80 Ring Road Completion
-
ScottsMiracle-Gro Provides Update on Fiscal 2024 Second Quarter
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
LTIMindtree Partners with Aforza to Setup Training Academy
-
Itronics Positioned to Benefit From Historic High and Rising Gold Prices
-
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis
-
Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Justice Climate Fund Selected by U.S. Environmental Protection Agency for Clean Communities Investment Accelerator Program
-
Bybit idealną platformą dla klientów instytucjonalnych dzięki nowemu narzędziu Dynamic Delta Hedging
-
Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metasta

